Healthy Skepticism Library item: 14997

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: report

Call for Ethical Clinical Trials in Developing Countries
Amsterdam: WEMOS Foundation 2009 Feb
http://www.fairdrugs.org/uploads/files/Call_for_Ethical_Clinical_Trials_in_Developing_Countries.pdf

Abstract:

Before a new drug can be released onto the market, it has to be tested on human subjects in
order to assess its efficacy and safety. Increasingly, the pharmaceutical industry is carrying out
these trials in developing countries.

For pharmaceutical companies, lower costs are an important reason to undertake trials in developing
countries. Trials can also be carried out more quickly because regulatory constraints
are less stringent, while the low level of income in developing countries means that people are
often more willing to participate. However, there are good reasons to believe that trial subjects
in these countries are more vulnerable than those in wealthier nations…